Bio-Rad Laboratories (BIO 17.63%), a global leader in life science research and clinical diagnostics, posted its second quarter 2025 financial results on July 31, 2025. The most important news was a clear earnings and revenue beat: Adjusted earnings per share (non-GAAP) were $2.61 in Q2 2025, well above the$1.73 non-GAAP analyst consensus for Q2 2025. Non-GAAP revenue reached $651.6 million in Q2 2025 compared to the$615.2 million non-GAAP revenue expectation. Sales saw slight growth compared to the same ...